Allstate Investment Management’s AbbVie ABBV Stock Holding History

Allstate Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$12.8M	Buy	+79,024	New	+$12.1M	0.39%	37

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allstate Investment Management's ABBV Position: Q4 2022 in Review

Allstate Investment Management opened a new position in AbbVie (ABBV) in Q4 2022: 79,024 shares worth $12.8M. The stake represents 0.39% of the portfolio and ranks #37 among its holdings.

3,171 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

Allstate Investment Management held 79,024 shares of AbbVie worth $12.8M as of Q4 2022.
AbbVie was a new Allstate Investment Management position in Q4 2022.
AbbVie made up 0.39% of Allstate Investment Management's portfolio in Q4 2022, its #37 holding.
3,171 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.